Patients with high lipoprotein lipase mRNA expression in B-cell chronic lymphocytic leukemia (B-CLL) demonstrate significantly higher MTA3 signaling activity, which is associated with adverse cytogenetic profiles, shorter time to first treatment, and reduced overall survival (65). Here, MTA3 is linked to B-cell chronic lymphocytic leukemia.